The Latest Breaking News on Pharma

WHO warns of 'extreme biohazard risk' as fighters occupy Sudan's national laboratory

The World Health Organization says that fighters in Sudan have occupied the national public laboratory holding samples of diseases including polio and measles, creating an "extremely, extremely dangerous" situation.

Radio France Internationale · Apr 25, 2023

King's Award for export success through Covid for pharma packaging firm launched in Grimsby

ALLpaQ recognised for outstanding international trade after role in US vaccine roll-out

Birmingham Post · Apr 25, 2023

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

The Guardian - UK · Apr 24, 2023

Top 3 Stocks to Sell in April With Weak Fundamentals

The biopharmaceutical industry has been grappling with various challenges, including inflation, the Fed’s hawkish stance, and new regulatory concerns. Hence, it could be wise to avoid Syndax Pharmaceuticals (SNDX), Senseonics Holdings (SENS), and Sio Gene Therapies (SIOX) due to their bleak fundamentals. Keep reading….

StockNews.com · Apr 20, 2023

Stay Away From These 3 Stocks With Bearish Momentum in April

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

StockNews.com · Apr 20, 2023

Supreme Court delays decision in abortion drug case

WASHINGTON — The Supreme Court gave itself more time on a decision expected Wednesday about a commonly used abortion drug, extending until Friday a temporary pause on a lower court ruling that would restrict availability of mifepristone.

Tribune News Service · Apr 20, 2023

Generic abortion pill maker sues FDA to protect access

A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington.

Tribune News Service · Apr 19, 2023

Supreme Court temporarily extends access to abortion pill

The court has given itself until Friday to rule on whether to allow restrictions to take effect on mifepristone as legal challenges to its FDA approval continue.

Chicago Sun-Times · Apr 19, 2023

Generic abortion pill manufacturer sues FDA in effort to preserve access

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

WEKU · Apr 19, 2023

Trade unions to urge Labour to make manifesto commitment to devolving drug law

TRADE Unions have agreed to urge Labour to include a commitment to devolve drug powers to Scotland in their next General Election manifesto.

The National (Scotland) · Apr 19, 2023